Trademark: FLORATEK PHARMA 2236867
Word
FLORATEK PHARMA
Device Descrption:
TREE,STYLISED CUTS HEXAGON
ID
2236867
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
13 October 2021
Registration Date
13 October 2021
Renewal Date
13 October 2031
Owner(s)
Service
Chrysiliou IP
Goods and Services:
Class 5:
Pharmaceutical products; pharmaceutical drugs; medicinal preparations and substances; all aforementioned goods excluding herbicides; herbicides for agricultural use; fungicides; fungicides for agricultural use; fungicides for horticultural use; turf fungicides; biological insecticides; chemicals for forestry (insecticides); insecticides; parasiticides; weedkillers; therapeutic preparations for the cardiovascular system; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases.
Pharmaceutical products; pharmaceutical drugs; medicinal preparations and substances; all aforementioned goods excluding herbicides; herbicides for agricultural use; fungicides; fungicides for agricultural use; fungicides for horticultural use; turf fungicides; biological insecticides; chemicals for forestry (insecticides); insecticides; parasiticides; weedkillers; therapeutic preparations for the cardiovascular system; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases.
Class 42:
Scientific research; pharmaceutical research; medicinal research; technical advice and product development for third parties in the field of pharmacy; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases.
Scientific research; pharmaceutical research; medicinal research; technical advice and product development for third parties in the field of pharmacy; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases.